Early Detection of Alzheimer's Disease with PET Imaging

Preclinical diagnosis of Alzheimer's disease (AD) is one of the major challenges for the prevention of AD. AD biomarkers are needed not only to reveal preclinical pathologic changes, but also to monitor progression and therapeutics. PET neuroimaging can reliably assess aspects of the molecular...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Berti, V., Osorio, R.S., Mosconi, L., Li, Y., De Santi, S., de Leon, M.J.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: S. Karger AG 2010
Pynciau:
Imaging, Biomarkers, Genetics and Diagnostic Markers
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3214828/
https://ncbi.nlm.nih.gov/pubmed/20197691
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000289222
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg